We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Kinase Assay Optimized

By Biotechdaily staff writers
Posted on 08 May 2007
A flexible and adaptable homogeneous technology for high-throughput screening (HTS) and ultra HTS (uHTS) was designed specifically for developing and optimizing sensitive assays for a variety of drug discovery targets, with a particular focus on applications for a wide range of kinase targets.

PerkinElmer, Inc. (Waltham, MA, USA), announced that it has expanded its successful portfolio of HTS Lance assays with the release of Lance Ultra. The improved time-resolved fluorescence resonance energy transfer (TR-FRET) technology accelerates speed and precision of kinase assay development and optimization.

"Protein kinases regulate several important functions within cells, such as growth, proliferation, and cell adhesion, making it one of the most important areas of study in today's pharmaceutical and biotech laboratories,” said Dr. Richard Eglen, vice president and general manager of the Discovery and Research Reagents business of PerkinElmer Life and Analytical Sciences. "The addition of Lance Ultra to PerkinElmer's broad offering of TR-FRET assay tools creates one of the industry's largest portfolios targeting high value functional biochemical and cell based assays.”

Lance Ultra utilizes ULight, an innovative, low-molecular weight red-shifted fluorescent dye that greatly enhances the performance of TR-FRET assays by increasing the range of targets that can be identified. Dr. Eglen said, "Dysregulation of kinase activity plays causal roles in many human diseases, making kinases one of today's most important drug discovery target classes.”

Lance Ultra reagents are specifically engineered for the precise development and optimization of kinase and enzyme assays, as well as for monitoring protein-protein interactions. Ultra high throughput screening applications such as Lance Ultra are easily adapted to any TR-FRET capable plate reader such as the PerkinElmer ViewLux uHTS imaging system or EnVision multimode reader, enabling greatly improved precision and remarkable throughput.

In addition to its broad range of traditional Lance technologies, PerkinElmer has significantly enhanced its custom reagents service, offering expert labeling of a wide variety of peptides, proteins and antibodies with PerkinElmer's proprietary europium and lanthanide chelate donor dyes, and ULight or allophycocyanin (APC) acceptor dyes.


Related Links:
PerkinElmer

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Manual Pipetting Aid
Pipette Controllers macro
New
Immunofluorescence Analyzer
IFA System

Latest BioResearch News

Single-Cell Method Measures RNA and Proteins to Reveal Immune Responses
08 May 2007  |   BioResearch

Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
08 May 2007  |   BioResearch

International Consensus Standardizes Tumor Microbiota Detection and Reporting
08 May 2007  |   BioResearch